4.7 Article

Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 128, Issue 1, Pages 94-104

Publisher

WILEY
DOI: 10.1002/ijc.25332

Keywords

MKK4; EMT; ovarian cancer; twist; NF-kappa B; E-cadherin

Categories

Ask authors/readers for more resources

In the current study, we investigated the mechanism relating downregulation of mitogen-activated protein kinase kinase 4 (MKK4) expression to development of ovarian cancer. Over-expression of the MKK4 gene in TOV-21 G cells, a line with homozygous deletion of MKK4, resulted in morphologic changes in which cells growing in a scattered, fibroblast-like pattern formed tightly packed colonies. Based on a wound healing assay and a Matrigel invasion assay, we determined that both motility and invasiveness of MKK4-transfected TOV-21G cells were significantly reduced compared to control vector-transfected cells. To confirm that MKK4 expression related to tumor invasion resulted from an epithelial to mesenchymal transition (EMT)-like morphological change, we used 2 independent but complementary approaches. MKK4 gene knockdown in MDAH 2774 cells over-expressing MKK4 increased invasion activity. Additionally, engineered expression of MKK4 in SKOV3 cells, a line with low endogenous MKK4 expression, produced a phenotype similar to that of TOVG-21G. Interestingly, we found that MKK4 upregulation caused downregulation of phosphorylated NF-kappa B and Twist, as well as upregulation of E-cadherin, in TOVG-21G and SKOV3 cells. Reciprocal results were obtained in MDAH 2774 cells with MKK4 knockdown. Our results suggest that MKK4 downregulation causes increased phosphorylation NF-kappa B. This promotes Twist over-expression, resulting in E-cadherin downregulation that induces EMT in ovarian cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

Kentaro Nakayama, Mohamed Tanjimur Rahman, Munmun Rahman, Kohei Nakamura, Masako Ishikawa, Hiroshi Katagiri, Emi Sato, Tomoka Ishibashi, Kouji Iida, Noriyuki Ishikawa, Satoru Kyo

INTERNATIONAL JOURNAL OF ONCOLOGY (2016)

Article Oncology

Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer

Kentaro Nakayama, Munmun Rahman, Mohammed Tanjimur Rahman, Kohei Nakamura, Emi Sato, Hiroshi Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Sultana Razia, Noriyuki Ishikawa, Satoru Kyo

ONCOLOGY LETTERS (2017)

Article Pathology

Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer

Munmun Rahman, Kentaro Nakayama, Mohammed Tanjimur Rahman, Hiroshi Katagiri, Atsuko Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Kohji Miyazaki

HUMAN PATHOLOGY (2013)

Article Oncology

Is ATP7B a Predictive Marker in Patients With Ovarian Carcinoma Treated With Platinum-Taxane Combination Chemotherapy?

Hiroshi Katagiri, Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, Atsuko Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Satoru Nakayama, Yoshiro Otsuki, Kohji Miyazaki

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)

Article Biochemistry & Molecular Biology

A Case of Stage III c Ovarian Clear Cell Carcinoma: The Role for Predictive Biomarkers and Targeted Therapies

Munmun Rahman, Kentaro Nakayama, Tomoka Ishibashi, Masako Ishikawa, Mohammed Tanjimur Rahman, Hiroshi Katagiri, Atsuko Katagiri, Kouji Iida, Yoshihiro Kikuchi, Kohji Miyazaki

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Oncology

Fatty Acid Synthase Is a Potential Therapeutic Target in Estrogen Receptor-/Progesterone Receptor-Positive Endometrioid Endometrial Cancer

Mohammed Tanjimur Rahman, Kentaro Nakayama, Masako Ishikawa, Munmun Rahman, Hiroshi Katagiri, Atsuko Katagiri, Tomoka Ishibashi, Kouji Lida, Kohji Miyazaki

ONCOLOGY (2013)

Article Biochemistry & Molecular Biology

IFN-gamma, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases

Mohammed T. Rahman, Chaitali Ghosh, Mohammed Hossain, Debra Linfield, Fariba Rezaee, Damir Janigro, Nicola Marchi, Anette H. H. van Boxel-Dezaire

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Ectopic Otoconin 90 expression in triple negative breast cancer cell lines is associated with metastasis functions

Alexander Pearlman, Mohammed Tanjimur Rahman, Kinnari Upadhyay, Johnny Loke, Harry Ostrer

PLOS ONE (2019)

Article Engineering, Biomedical

Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis

Sivakumar Vijayaraghavalu, Yue Gao, Mohammed Tanjimur Rahman, Richard Rozic, Nima Sharifi, Ronald J. Midura, Vinod Labhasetwar

BIOMATERIALS (2020)

Article Cell Biology

Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages

Mohammed Tanjimur Rahman, Santoshi Muppala, Jiahui Wu, Irene Krukovets, Dmitry Solovjev, Dmitriy Verbovetskiy, Chioma Obiako, Edward F. Plow, Olga Stenina-Adognravi

CELL DEATH & DISEASE (2020)

Article Chemistry, Multidisciplinary

Nanoparticle-mediated synergistic drug combination for treating bone metastasis

Mohammed Tanjimur Rahman, Youzhi Kaung, Logan Shannon, Charlie Androjna, Nima Sharifi, Vinod Labhasetwar

Summary: Bone metastasis at an advanced disease stage is common and untreatable. Overexpression of RANKL in tumor-bone marrow microenvironment drives tumor progression and bone resorption. Evaluation of biodegradable nanoparticles localized in tumor tissue showed that the combination treatment with docetaxel and Denosumab completely regressed the tumor, preventing bone resorption without causing mortality.

JOURNAL OF CONTROLLED RELEASE (2023)

Article Oncology

Non-Hodgkin lymphoma of the female genital tract mimicking primary gynecological tumors: a single-center series of 3 cases

M. Rahman, K. Nakayama, M. T. Rahman, M. Ishikawa, H. Katagiri, A. Katagiri, E. Sato, K. Iida, K. Miyazaki

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (2016)

Article Oncology

Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report

M. Ishikawa, K. Nakayama, M. T. Rahman, M. Rahman, H. Katagiri, A. Katagiri, T. Ishibashi, K. Iida, N. Nakayama, K. Miyazaki

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY (2014)

Article Oncology

ESR1 Gene Amplification in Endometrial Carcinomas: A Clinicopathological Analysis

Mohammed Tanjimur Rahman, Kentaro Nakayama, Munmun Rahman, Masako Ishikawa, Hiroshi Katagiri, Atsuko Katagiri, Tomoka Ishibashi, Emi Sato, Kouji Iida, Noriyuki Ishikawa, Naomi Nakayama, Kohji Miyazaki

ANTICANCER RESEARCH (2013)

Article Oncology

PPP2R1A Mutation Is a Rare Event in Ovarian Carcinoma Across Histological Subtypes

Munmun Rahman, Kentaro Nakayama, Mohammed Tanjimur Rahman, Naomi Nakayama, Hiroshi Katagiri, Atsuko Katagiri, Tomoka Ishibashi, Masako Ishikawa, Kouji Iida, Yoshiro Otsuki, Satoru Nakayama, Kohji Miyazaki

ANTICANCER RESEARCH (2013)

Article Oncology

Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV

Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa

Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.

INTERNATIONAL JOURNAL OF CANCER (2024)